These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28770638)

  • 21. Irregular tick-borne encephalitis vaccination schedules: the effect of a single catch-up vaccination with FSME-IMMUN. A prospective non-interventional study.
    Schosser R; Reichert A; Mansmann U; Unger B; Heininger U; Kaiser R
    Vaccine; 2014 Apr; 32(20):2375-81. PubMed ID: 24613521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?
    Zent O; Plentz A; Schwarz TF; Frühwein N; Kuhr HB; Broeker M; Banzhoff A; Jilg W
    Vaccine; 2004 Dec; 23(3):312-5. PubMed ID: 15530673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase 3 immunogenicity and safety study of a tick-borne encephalitis vaccine in healthy Japanese participants 1 year of age and older.
    Yonekawa M; Watanabe T; Kogawara O; Yoshii C; Yamaji M; Aizawa M; Erber W; Ito S; Jug B; Koelch D; de Solom R; Lockhart SP
    Vaccine; 2024 May; 42(13):3180-3189. PubMed ID: 38614954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trial.
    Kantele A; Rombo L; Vene S; Kundi M; Lindquist L; Erra EO
    Vaccine; 2022 Feb; 40(9):1299-1305. PubMed ID: 35101266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.
    Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Firth C; Petermann R; Barrett PN; Ehrlich HJ
    Vaccine; 2011 Oct; 29(43):7307-19. PubMed ID: 21843576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seropersistence and booster response following vaccination with FSME-IMMUN in children, adolescents, and young adults.
    Poellabauer E; Angermayr R; Behre U; Zhang P; Harper L; Schmitt HJ; Erber W
    Vaccine; 2019 May; 37(24):3241-3250. PubMed ID: 30928173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study.
    Hertzell KB; Pauksens K; Rombo L; Knight A; Vene S; Askling HH
    Vaccine; 2016 Jan; 34(5):650-655. PubMed ID: 26718689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up.
    Rendi-Wagner P; Paulke-Korinek M; Kundi M; Wiedermann U; Laaber B; Kollaritsch H
    Vaccine; 2007 Jun; 25(27):5097-101. PubMed ID: 17555850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of antibodies after vaccination against tick-borne encephalitis.
    Rendi-Wagner P; Zent O; Jilg W; Plentz A; Beran J; Kollaritsch H
    Int J Med Microbiol; 2006 May; 296 Suppl 40():202-7. PubMed ID: 16524776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. After a tick bite in a tick-borne encephalitis virus endemic area: current positions about post-exposure treatment.
    Bröker M; Kollaritsch H
    Vaccine; 2008 Feb; 26(7):863-8. PubMed ID: 18206274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity of delayed TBE-vaccine booster.
    Askling HH; Vene S; Rombo L; Lindquist L
    Vaccine; 2012 Jan; 30(3):499-502. PubMed ID: 22122857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation.
    Rendi-Wagner P; Kundi M; Zent O; Banzhoff A; Jaehnig P; Stemberger R; Dvorak G; Grumbeck E; Laaber B; Kollaritsch H
    Vaccine; 2004 Dec; 23(4):427-34. PubMed ID: 15530690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults.
    Konior R; Brzostek J; Poellabauer EM; Jiang Q; Harper L; Erber W
    Vaccine; 2017 Jun; 35(28):3607-3613. PubMed ID: 28545923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?
    Rendi-Wagner P; Kundi M; Zent O; Dvorak G; Jaehnig P; Holzmann H; Mikolasek A; Kollaritsch H
    Vaccine; 2004 Jul; 22(21-22):2743-9. PubMed ID: 15246606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.
    Paulke-Korinek M; Kollaritsch H; Kundi M; Zwazl I; Seidl-Friedrich C; Jelinek T
    Vaccine; 2015 Jul; 33(30):3600-4. PubMed ID: 26036947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and safety of rapid scheme vaccination against tick-borne encephalitis in HIV-1 infected persons.
    Jilich D; Maly M; Kosina P; Fleischhans L; Machala L
    Epidemiol Infect; 2021 Jan; 149():e41. PubMed ID: 33504405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study.
    Jílková E; Vejvalková P; Stiborová I; Skorkovský J; Král V
    Expert Opin Biol Ther; 2009 Jul; 9(7):797-803. PubMed ID: 19527104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of delayed TBE-vaccine booster after primary vaccination.
    Aerssens A; Cochez C; Niedrig M; Heyman P; Kühlmann-Rabens I; Soentjens P
    J Travel Med; 2016 Feb; 23(2):tav020. PubMed ID: 26858269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of the serological response after vaccination against tick-borne encephalitis in Sweden.
    Vene S; Haglund M; Lundkvist A; Lindquist L; Forsgren M
    Vaccine; 2007 Jan; 25(2):366-72. PubMed ID: 16959384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of immunity to tick-borne encephalitis after vaccination and natural infection.
    Baldovin T; Mel R; Bertoncello C; Carpenè G; Soppelsa F; Giliberti A; Baldo V
    J Med Virol; 2012 Aug; 84(8):1274-8. PubMed ID: 22711356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.